179 related articles for article (PubMed ID: 30005852)
1. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
[TBL] [Abstract][Full Text] [Related]
2. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
Tsuchiya KD; Davis B; Gardner RA
Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
[TBL] [Abstract][Full Text] [Related]
3. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
[TBL] [Abstract][Full Text] [Related]
4. Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.
Baughn LB; Biegel JA; South ST; Smolarek TA; Volkert S; Carroll AJ; Heerema NA; Rabin KR; Zweidler-McKay PA; Loh M; Hirsch B
Cancer Genet; 2015; 208(1-2):1-18. PubMed ID: 25678190
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
[TBL] [Abstract][Full Text] [Related]
6. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
[TBL] [Abstract][Full Text] [Related]
8. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG
Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686
[TBL] [Abstract][Full Text] [Related]
9. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
[TBL] [Abstract][Full Text] [Related]
10. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
[TBL] [Abstract][Full Text] [Related]
11. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population.
Fuka G; Farias-Vieira TM; Hummel L; Blunck CB; Santoro JC; Terra-Granado E; Barbosa TC; Emerenciano M; Pombo-de-Oliveira MS
Mol Cytogenet; 2015; 8():35. PubMed ID: 26060508
[TBL] [Abstract][Full Text] [Related]
13. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy.
Sinclair PB; Parker H; An Q; Rand V; Ensor H; Harrison CJ; Strefford JC
Hum Mol Genet; 2011 Jul; 20(13):2591-602. PubMed ID: 21487021
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia.
Ivanov Öfverholm I; Zachariadis V; Taylan F; Marincevic-Zuniga Y; Tran AN; Saft L; Nilsson D; Syvänen AC; Lönnerholm G; Harila-Saari A; Nordenskjöld M; Heyman M; Nordgren A; Nordlund J; Barbany G
Leuk Lymphoma; 2020 Mar; 61(3):604-613. PubMed ID: 31640433
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
18. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA
J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221
[TBL] [Abstract][Full Text] [Related]
19. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB
Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717
[TBL] [Abstract][Full Text] [Related]
20. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Strefford JC; van Delft FW; Robinson HM; Worley H; Yiannikouris O; Selzer R; Richmond T; Hann I; Bellotti T; Raghavan M; Young BD; Saha V; Harrison CJ
Proc Natl Acad Sci U S A; 2006 May; 103(21):8167-72. PubMed ID: 16702559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
